Franklin M Berger's Net Worth

$6.48 Million

Estimate Recalculated May 6, 2024 04:18PM EST

Who is Franklin M Berger?

Franklin M Berger has an estimated net worth of $6.48 Million. This is based on reported shares across multiple companies, which include Rain Oncology Inc., SEATTLE GENETICS INC /WA, IMMUNE DESIGN CORP., Kezar Life Sciences, Inc., Atea Pharmaceuticals, Inc., BIOTIME INC, ESSA Pharma Inc., Tocagen Inc, Atreca, Inc., PROTEOSTASIS THERAPEUTICS, INC., EMISPHERE TECHNOLOGIES INC, FIVE PRIME THERAPEUTICS, INC., VAXGEN INC, and Asterias Biotherapeutics, Inc..

SEC CIK

Franklin M Berger's CIK is 0001273885

Past Insider Trading and Trends

2005 was Franklin M Berger's most active year for acquiring shares with 27 total transactions. Franklin M Berger's most active month to acquire stocks was the month of November. 2021 was Franklin M Berger's most active year for disposing of shares, totalling 11 transactions. Franklin M Berger's most active month to dispose stocks was the month of November. 2021 saw Franklin M Berger paying a total of $3,882,309.24 for 1,020,039 shares, this is the most they've acquired in one year. In 2019 Franklin M Berger cashed out on 265,295 shares for a total of $756,102.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Rain Oncology Inc. (RAIN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.01M
—
—
0
Jan 26
Form 4
—
0
—
—
0
Aug 9
Form 4
+13.81%
122K
$8.10
$987,790.00
1.01M
Nov 21 - Nov 22
Form 4
+5.10%
42.88K
$5.83
$249,996.23
883.21K
Nov 8
Form 4
—
0
—
—
0
Jun 1
Form 4
+0.45%
3.79K
$14.30
$54,139.80
840.33K
Sep 21
Form 4
—
0
—
—
0
May 14
Form 4
∞
836.54K
$16.95
—
836.54K
Apr 23 - Apr 27
Form 3
—
0
—
—
0
No matching records found

SEATTLE GENETICS INC /WA (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.80%
7.5K
$12.76
$95,700.00
204.72K
Feb 21
Form 4
+5.34%
10K
$12.76
$127,600.00
197.22K
Aug 28
Form 4
+1.91%
3.5K
—
—
187.22K
May 17
Form 4
+12.22%
20K
$10.14
$202,800.00
183.72K
Aug 23
Form 4
—
0
—
—
0
May 18
Form 4
+4.47%
7K
$20.04
$140,273.70
163.72K
Jun 22
Form 4
—
0
—
—
0
May 20
Form 4
+3.30%
5K
$8.38
$41,900.00
156.72K
Oct 1
Form 4
+9.37%
13K
$7.55
$98,140.00
151.72K
Aug 24
Form 4
—
0
—
—
0
May 21
Form 4
+18.85%
22K
$8.47
$186,375.00
138.72K
May 13 - May 14
Form 4
+10.93%
11.5K
$12.05
$138,527.85
116.72K
Mar 30
Form 4
+14.10%
13K
$11.90
$154,713.50
105.22K
Mar 10 - Mar 12
Form 4
+12.16%
10K
$5.11
$51,100.00
92.22K
Dec 29
Form 4
+6.48%
5K
$4.18
$20,900.00
82.22K
Oct 7
Form 4
+6.92%
5K
$4.18
$20,900.00
77.22K
Jul 29
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 16
Form 4
+0.74%
528
$9.12
$4,815.36
72.22K
Jan 22
Form 4
—
0
—
—
0
May 25
Form 4
+16.21%
10K
$4.20
$41,976.98
71.69K
Aug 15
Form 4
—
0
—
—
0
May 19
Form 4
+47.97%
20K
$4.81
$96,128.64
61.69K
Dec 29 - Dec 30
Form 4
+98.53%
20.69K
$5.01
$103,690.77
41.69K
Dec 23 - Dec 27
Form 4
—
0
—
—
0
May 13
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 30
No matching records found

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-75.00K
$5.85
-$438,750.00
0
Apr 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
+50.00%
25K
$4.58
$114,375.00
75K
Oct 30
Form 4
+100.00%
25K
$4.26
$106,620.00
50K
Oct 25
Form 4
—
0
—
—
0
Jan 4
Form 4
-66.67%
-50.00K
$6.55
-$327,330.00
25K
Dec 16
Form 4
—
0
—
—
0
Jan 4
Form 4
+50.00%
25K
$26.50
$662,500.00
75K
Apr 21
Form 4
—
0
—
—
0
Jan 7
Form 4
∞
50K
$12.00
$600,000.00
50K
Jul 29
Form 3
—
0
—
—
0
No matching records found

Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.949

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 24
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
+9.87%
80K
$16.25
$1,299,800.00
890.69K
Mar 18 - Mar 21
Form 4
+3.40%
26.69K
$6.38
$170,269.44
810.69K
Sep 21 - Sep 22
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 24
Form 4
+14.62%
100K
$5.50
$550,000.00
784K
Jun 11
Form 4
+21.46%
120.85K
$2.60
$314,199.60
684K
Feb 4
Form 4
—
0
—
—
0
Jun 25
Form 4
+959.08%
509.98K
$15.00
—
563.16K
Jun 25
Form 3
—
0
—
—
0
No matching records found

Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $4.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
-5.08%
-41.67K
$5.15
-$214,684.55
778.35K
Nov 11 - Nov 14
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 18
Form 4
+4,274.13%
801.27K
$24.00
—
820.02K
Nov 3
Form 4
—
0
—
—
0
Oct 29
Form 3
—
0
—
—
0
No matching records found